This discussion will address the operational challenges in the cell and gene therapy space pertaining to supply chain operations and site activation.
Key areas include:
Identifying differences between traditional execution of getting these programs delivered? How is it different?
What are the new technologies out there helping us to try and solve this problem? What digital platforms are being pushed?
- What are the issues at the site level that we need to be aware of?
- Each group is trying to implement their own standards, and those standards differ across companies.
- The sites are trying to cater to multiple types of standards. There is no harmonization at the site level.